Latest news
Latigo Biotherapeutics Raises 345 Million Dollars in Nasdaq IPO - sekbernews.idsekbernews.id · Sat, 08 Aug 2026 10:25:39 GMTLatigo IPO raises nearly $350M for pain drug development - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 13:05:46 GMTCardiac drug developer Braveheart banks more than $382M in IPO - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 03:18:37 GMT